1 All subjects must fulfill the published criteria for the diagnosis of ALPS documented nonmalignant lymphadenopathy and/or splenomegaly of at least 1-year duration greater than1 TCR alpha/beta+ CD4-CD8- T cells in the peripheral blood This must include clinically documented lymphadenopathy involving more than 2 nodes in more than 1 regional group of nodes measuring greater than 2cm in size and/or a palpable spleen 